AdvisorShares Psychedelics ETF PSIL
19.71 USD -0.36 (-1.81%)
Nov 12, 2026, 11:41 AM EST
19.49 Day range 19.84
15.64 52-week range 27.02
- YTD
- +14.77%
- 1 year
- +4.60%
News
benzinga.com NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug The FDA signals its willingness to review NRx Pharmaceuticals' NRX-100 NDA, boosting optimism around its depression treatment.
benzinga.com COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy Compass Pathways' stock surges after late-stage depression trial success.
benzinga.com Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug Quantum Biopharma's subsidiary, Huge Biopharma Australia, has cleared a regulatory milestone for its neuroprotective compound, Lucid-MS, in a Phase 1 trial.
benzinga.com 'Texas Governor Signs Bill To Create Ibogaine Research Consortium, Aiming To Develop FDA-Approved Psychedelic Drug' - Marijuana Moment https://www.marijuanamoment.net/texas-governor-signs-bill-to-create-ibogaine-research-consortium-aiming-to-develop-fda-approved-psychedelic-drug/
benzinga.com "Colorado Governor Says Bill He Signed Allowing Psychedelic Convictions To Be Pardoned Marks A Step 'Towards A Fairer Future'" - Marijuana Moment https://www.marijuanamoment.net/colorado-governor-says-bill-he-signed-allowing-psychedelic-convictions-to-be-pardoned-marks-a-step-towards-a-fairer-future/
benzinga.com 'Doctor Seeking To Reschedule Psilocybin To Treat Dying Patients Demands DEA Update After Agency Agreed To Initiate Federal Review' - Marijuana Moment https://www.marijuanamoment.net/doctor-seeking-to-res